HAEMONETICS CORP (HAE) — Revenue

Annual figures by fiscal year, from SEC filings.

2017: $886.12M2018: $903.92M2019: $967.58M2020: $988.48M2021: $870.46M2022: $993.20M2023: $1.17B2024: $1.31B2025: $1.36B2026: $1.33B$1.33B
2017Revenue (USD)2026
Fiscal YearRevenueChange YoY
2026$1.33B-2.0%
2025$1.36B+4.0%
2024$1.31B+12.0%
2023$1.17B+17.7%
2022$993.20M+14.1%
2021$870.46M-11.9%
2020$988.48M+2.2%
2019$967.58M+7.0%
2018$903.92M+2.0%
2017$886.12M